CLDF Title
Home | Contact Us | Bookmark
About CLDF Centers of Educational Expertise  
Webcasts Slide Library Abstract Library Conference Highlights
Reuters Health Information (2006-09-26): WHO approves new child vaccine


WHO approves new child vaccine

Last Updated: 2006-09-26 13:27:02 -0400 (Reuters Health)

AMSTERDAM (Reuters) - The World Health Organization (WHO) gave Dutch biotech firm Crucell the green light on Tuesday to start selling a new vaccine for protection against five major childhood diseases.

The vaccine, Quinvaxem, offers protection against diphtheria, tetanus, whooping cough, hepatitis B and Haemophilus influenzae type b.

Crucell said in a statement that WHO's decision to grant "prequalification" meant it could start selling Quinvaxem to aid organisations UNICEF and PAHO, the Pan American Health Organisation.

Crucell estimates the current demand for the Quinvaxem vaccine at more than 50 million doses, with annual demand expected to increase to more than 150 million per year over the next five years.

Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
CLDF Follow Us
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
Centers of
Educational Expertise
Regional Map
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2015 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.